Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma

    Not recruiting

    1 1 1 1
    Spain
  • Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Norway Slovakia Sweden
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy The Netherlands +2
  • Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Italy Poland +2
  • Study on the Safety and Effectiveness of 166Holmium Radiation Therapy with Atezolizumab and Bevacizumab for Patients with Non-Resectable Liver Cancer

    Not recruiting

    2 1 1 1
    France
  • Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

    Not recruiting

    3 1 1 1
    Belgium France Germany Italy Portugal Spain
  • Study of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)

    Not recruiting

    1 1 1
    Investigated diseases:
    France Germany Italy Poland Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Belgium Spain
  • Study of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Ireland